SIBN News and Press, SI-BONE Inc. From 08/07/23

SANTA CLARA, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2023. Recent Highlights Record wo...

SANTA CLARA, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2023 Canaccord Genuity 43rd Annual Growth...

SANTA CLARA, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2023 after market close on Monday, Au...

2023-06-15 12:14:52 ET Summary SI-BONE is pushing higher in revenues and gross profit, clipping another strong quarter. It pulled in 80% gross margin and expects this on a revised FY'23 outlook. Additional fundamental catalysts are the revised Granite segment outlook and incre...

SANTA CLARA, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2023 Jefferies Healthcare Conference in Ne...

2023-05-04 16:45:47 ET SI-BONE ( NASDAQ: SIBN ) said Thursday it has commenced an underwritten public offering of 3.8 million shares of its common stock. Shares -4.9% at $23.26 after hours. Of the shares being offered, 3,502,247 shares are being offered by SI...

2023-05-02 14:12:23 ET Shares of medical equipment company Si-Bone (NASDAQ: SIBN) were up more than 20% Tuesday morning before falling to a rise of just over 9% Tuesday afternoon after the healthcare company released first-quarter earnings. The stock is up more than 17% so far this ...

2023-05-02 10:02:29 ET Gainers: TScan Therapeutics ( TCRX ) +17% . Vivani Medical ( VANI ) +15% . SI-BONE ( SIBN ) +13% . Kiniksa Pharmaceuticals ( KNSA ) +12% . Harmony Biosciences ( HRMY ) +8% . Losers: Community Health ...

2023-05-01 22:20:02 ET SI-BONE, Inc. (SIBN) Q1 2023 Earnings Conference Call May 1, 2023, 16:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group Laura Francis - Chief Executive Officer Anshul Maheshwari - Chief Financial Officer Conference Call...

2023-05-01 16:17:56 ET SI-BONE press release ( NASDAQ: SIBN ): Q1 GAAP EPS of -$0.32 beats by $0.10 . Revenue of $32.71M (+45.8% Y/Y) beats by $3.55M . Record U.S. revenue of $30.5 million for the first quarter 2023, representing approximately 50% inc...